5-lipoxygenase inhibitory thiazoles
US5089513A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | Jul 11, 1989 |
| Grant date | Feb 18, 1992 |
| Priority date | — |
| Expiry date | Jul 11, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D277/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a thiazole of the formula I, ##STR1## wherein Ar.sup.1 is optionally substituted aryl of up to 10 carbon atoms; PA0 A is a direct link to X, or is (1-6C)alkylene, (3-6C)alkenylene, (3-6C)alkynylene or cyclo(3-6C)alkylene; PA0 X is oxy, thio, sulphinyl, sulphonyl or imino; PA0 Ar.sup.2 is optionally substituted phenylene, or a 6-membered heterocyclene moiety containing up to three nitrogen atoms; PA0 R.sup.1 is hydrogen, (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl or substituted (1-4C)alkyl; PA0 R.sup.2 is hydrogen, (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, substituted (1-4C)alkyl or (2-6C)alkanoyl; PA0 Q is optionally substituted thiazolyl; or a pharmaceutically-acceptable salt thereof. The invention also concerns processes for the manufacture of a thiazole of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said thiazole.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.